Search the Newsreel

Phreesia director Lisa Egbuonu-Davis sells $5,735 in stock

Phreesia director Lisa Egbuonu-Davis sold 536 shares of Phreesia, Inc. stock for $5,735 on July 14, 2026, as part of a Rule 10b5-1 trading plan. Following the sale, she directly holds 37,780 shares. The company recently reported strong Q1 fiscal 2027 earnings, surpassing expectations, …

Phreesia, Inc. SEC Filing

This SEC filing (Form 144) for Phreesia, Inc. (PHR) details Yvonne Hui's intent to sell 1,247 shares of common stock, valued at $13,617.24, acquired through restricted stock vesting. The filing also reports several previous sales of PHR common stock by Yvonne Hui within the …

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Phreesia, Inc. of Class Action Lawsuit and Upcoming Deadlines - PHR

Pomerantz LLP has filed a class action lawsuit against Phreesia, Inc. (NYSE: PHR) following a significant drop in its stock price after the company announced reduced revenue growth projections for fiscal year 2027. Investors who purchased Phreesia securities during the Class Period are encouraged …

PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm has announced a class action lawsuit against Phreesia, Inc. (NYSE: PHR) for alleged securities fraud, inviting investors who purchased the company's securities between May 8, 2025, and March 30, 2026, to participate. The lawsuit alleges that Phreesia made false and …

Phreesia (PHR) Q2 2025 earnings summary

Phreesia (PHR) achieved positive free cash flow for the first time as a public company in Q2 2025, reaching $3.7 million, alongside significant improvements in revenue, net loss, and Adjusted EBITDA. The company reported a 19% year-over-year revenue growth to $102.1 million and narrowed …

Enterprise value to revenue forward of Phreesia, Inc. – NYSE:PHR

This article provides the enterprise value to revenue forward for Phreesia, Inc. (NYSE: PHR). It briefly lists the company's stock exchange, sector, and provides a navigation path to its financial data on TradingView. The content itself is very minimal, focusing on the title as …

Nephros Inc. (NEPH) Q1 2026 Earnings: EPS Misses Estimate by Narrow Margin, Stock Declines - Earnings Power Value

Nephros joins Russell Microcap Index after annual reconstitution

Nephrocare Health Services IPO Day 3: Check live subscription status, allotment date and steps

Nephros Q1 2026 Earnings: EPS Slightly Misses Estimate, Stock Dips 4.7% - Earnings Decline Risk

Nephrocare Health Services Schedules Q4FY26 Earnings Conference Call for May 20, 2026

Nephrocare Health Services profit up 75% in FY26 on strong dialysis demand

Earnings call transcript: Nephros Q1 2026 revenue beats forecast, stock rises

Nephrocare Health Services Ltd Share Price Today – Live NSE/BSE

Nephrocare Health share price: Stock lists at 6.5% premium on NSE; here's how much investors made per lot

Nephrocare Health IPO: Top 10 key risks investors must know before subscribing to the issue; check latest GMP here